EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Alpha 3

Ensembl ID : ENSG00000105409
Gene: ATP1A3
Gene Synonyms: DYT12
6 APIs:
10 Enzyme and pathways 9 Cross references
134 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Atpase Na+/k+ Transporting Subunit Alpha 4

Ensembl ID : ENSG00000132681
Gene: ATP1A4
Gene Synonyms: ATP1AL2
6 APIs:
10 Enzyme and pathways 7 Cross references
571 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSG00000143153
Gene: ATP1B1
Gene Synonyms: ATP1B
6 APIs:
13 Enzyme and pathways 8 Cross references
288 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSG00000129244
Gene: ATP1B2
Gene Synonyms: AMOG
6 APIs:
13 Enzyme and pathways 7 Cross references
269 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Atr Serine/threonine Kinase

Ensembl ID : ENSG00000175054
Gene: ATR
Gene Synonyms: FRP1,MEC1,SCKL,SCKL1
4 APIs:
34 Enzyme and pathways 9 Cross references
207 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSG00000167601
Gene: AXL
Gene Synonyms: ARK,JTK11,TYRO7,UFO
5 APIs:
4 Enzyme and pathways 8 Cross references
198 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSG00000157764
Gene: BRAF
Gene Synonyms: BRAF-1,BRAF1
14 APIs:
39 Enzyme and pathways 9 Cross references
211 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Bcl2 Apoptosis Regulator

Ensembl ID : ENSG00000171791
Gene: BCL2
Gene Synonyms: BCL-2,PPP1R50
4 APIs:
20 Enzyme and pathways 9 Cross references
228 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Bcl2 Like 1

Ensembl ID : ENSG00000171552
Gene: BCL2L1
Gene Synonyms: BCL-X,BCL-XL,BCL-XS,BCL2L,BCLX,PPP1R52
2 APIs:
27 Enzyme and pathways 7 Cross references
289 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Bcl2 Like 10

Ensembl ID : ENSG00000137875
Gene: BCL2L10
Gene Synonyms: BCL-B,BOO,DIVA
1 APIs:
7 Cross references
129 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Bcl2 Like 2

Ensembl ID : ENSG00000129473
Gene: BCL2L2
Gene Synonyms: BCL-W,KIAA0271,PPP1R51
2 APIs:
7 Cross references
64 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Bcl2 Related Protein A1

Ensembl ID : ENSG00000140379
Gene: BCL2A1
Gene Synonyms: ACC-1,ACC-2,ACC1,ACC2,BCL2L5,BFL1,GRS,HBPA1
1 APIs:
5 Enzyme and pathways 7 Cross references
133 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).